EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 7

Amla Phyllanthus emblica L.

Also called: Indian gooseberry, amalaki, emblic, emblic myrobalan, Emblica officinalis (synonym)

Amla (Indian gooseberry) is the fruit of Phyllanthus emblica, eaten as food and used in Ayurveda as a Rasayana (rejuvenative tonic). Supplements use the dried fruit or fruit extracts; the fruit is a rich source of vitamin C.

Category
Botanical
Part used
Fruit (dried)
Strongest evidence
B Some positive trials
Native range
Native to tropical and subtropical Asia (POWO/WCVP: "Trop. & Subtrop. Asia")
Reviewed
2026-10-29

Class 1 Well studied in people. A 2023 systematic review and meta-analysis (BMC Complement Med Ther) included 9 RCTs (535 adults) of oral Emblica officinalis fruit alone, excluding polyherbal formulas: 8 used aqueous fruit extract and 1 dried fruit powder, all in capsules. [2]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied3 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Amla does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Amla, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood lipids and C-reactive protein in adultsBA 2023 meta-analysis of nine RCTs (535 adults; 500-1,500 mg/day for 14-84 days) found lower LDL-C (-15.08 mg/dL), triglycerides and hsCRP than placebo; heterogeneity was high and authors urged caution. [2]
Fasting blood glucose in adultsBA 2023 meta-analysis of five RCTs (3-12 weeks) found lower fasting blood glucose and improved lipids with amla; authors called for more studies. [3]
Antimicrobial, anticancer, liver and other effectsDA 2022 review describes these mainly from in vitro and animal studies and notes earlier reports often lacked dose, standards and controls. [1]

Main constituents: Tannins, flavonoids, saponins, terpenoids, alkaloids and ascorbic acid; the fruit is a rich source of vitamin C, minerals and amino acids [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Trials in the 2023 cardiovascular meta-analysis used 500 to 1,500 mg/day for 14 to 84 days. [2]
  • Stated in Health Canada's monograph (Canada, March 28, 2025), adults: 3-6 g dried fruit per day for traditional Ayurvedic uses; not to exceed 6 g dried fruit per day as an antioxidant. [4]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Health Canada: products providing more than 3 g amla a day must advise asking a practitioner before use if pregnant; all products, if breastfeeding.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    1 listed

    Other medications or health products

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    3 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Stated in Health Canada's monograph (Canada, March 28, 2025), adults: 3-6 g dried fruit per day for traditional Ayurvedic uses …

    Details and sources
  • A laxative effect may occur. [4]
  • Health Canada: ask a health care practitioner before use if breastfeeding, or if pregnant when taking more than 3 g a day. [4]
  • Toxicology studies of the fruit in animals found no adverse effect even at high oral doses. [1]
Interactions

Interactions

Known interactions of Amla
WithWhat happens
Other medications or health productsHealth Canada directs taking amla a few hours before or after other medications or health products. [4]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Regulation

Regulatory status

  • Canada: Health Canada monograph (March 28, 2025) for traditional Ayurvedic uses and as a source of antioxidants. [4]
  • US: FDA states that, by law, it does not approve dietary supplements or their labeling; under DSHEA it has no authority to approve them before they are marketed, and firms are responsible for their products' safety and labeling. [5]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Tannins Polyphenols (tannins) [P1]
  • Ascorbic acid (vitamin C) Vitamin [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 3 entries naming Phyllanthus emblica (Emblica officinalis), each as one ingredient of a multi-ingredient combination (earliest NDI 128 submitted 2001-11-09; most recent NDI 862 submitted 2015-02-12). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of amla (Phyllanthus emblica) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • Other medications or health products: Health Canada directs taking amla a few hours before or after other medications or health products. [P4]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component before use — 21 CFR 111.75(a)(1)(i) requires at least one appropriate identity test or examination unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P5]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29 [P6]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Stated in Health Canada's monograph (Canada, March 28, 2025), adults: 3-6 g dried fruit per day for traditional Ayurvedic uses; not to exceed 6 g dried fruit per day as an antioxidant. [P4]

Pregnancy and breastfeeding

  • Health Canada: products providing more than 3 g amla a day must advise asking a practitioner before use if pregnant; all products, if breastfeeding. [P4]

Sources for this profile

  1. Saini R, et al. Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: a comprehensive review. J Ethnopharmacol 2022;282:114570 (PMID 34480995), 2022-01-10. pubmed.ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs on the Identification of Carcinogenic Hazards to Humans. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  4. Health Canada, Natural and Non-prescription Health Products Directorate. Monograph: Amla - Phyllanthus emblica (dated March 28, 2025), 2025-03-28. webprod.hc-sc.gc.ca
  5. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, checked 2026-10-29), 2026-10-29. ecfr.gov
  6. GBIF species API: IUCN Red List category for Phyllanthus emblica, 2026-10-29. api.gbif.org
Sources

Sources

  1. Saini R, et al. Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: a comprehensive review. J Ethnopharmacol 2022;282:114570 (PMID 34480995), 2022-01-10. pubmed.ncbi.nlm.nih.gov
  2. Brown PDS, et al. Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis. BMC Complement Med Ther 2023;23(1):190 (PMID 37296402), 2023-06-09. pubmed.ncbi.nlm.nih.gov
  3. Setayesh L, et al. The impact of Emblica officinalis (amla) on lipid profile, glucose, and C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2023;17(3):102729 (PMID 36934568), 2023-03. pubmed.ncbi.nlm.nih.gov
  4. Health Canada, Natural and Non-prescription Health Products Directorate. Monograph: Amla - Phyllanthus emblica (dated March 28, 2025), 2025-03-28. webprod.hc-sc.gc.ca
  5. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  6. World Checklist of Vascular Plants (WCVP, the taxonomic index to POWO; GBIF dataset f382f0ce, 2026-06-04): Phyllanthus emblica L., accepted, native range "Trop. & Subtrop. Asia" (retrieved 2026-10-29 via GBIF species API; POWO page could not be loaded), 2026-10-29. api.gbif.org
  7. WCVP via GBIF species API: Emblica officinalis Gaertn., synonym of Phyllanthus emblica L. (retrieved 2026-10-29), 2026-10-29. api.gbif.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · Ashwagandha · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.